Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
Crossref DOI link: https://doi.org/10.1007/s00125-014-3278-9
Published Online: 2014-06-04
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abbasi, Ali
Corpeleijn, Eva
Gansevoort, Ron T.
Gans, Rijk O. B.
Struck, Joachim
Schulte, Janin
Hillege, Hans L.
van der Harst, Pim
Stolk, Ronald P.
Navis, Gerjan
Bakker, Stephan J. L.
License valid from 2014-06-04